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Substance dependence among those without symptoms of substance abuse in 
the World Mental Health Survey 
Abstract 
The World Health Organization (WHO) World Mental Health (WMH) Survey Initiative uses the Composite 
International Diagnostic Interview (CIDI). The first 13 surveys only assessed substance dependence 
among respondents with a history of substance abuse; later surveys also assessed substance 
dependence without symptoms of abuse. We compared results across the two sets of surveys to assess 
implications of the revised logic and develop an imputation model for missing values of lifetime 
dependence in the earlier surveys. Lifetime dependence without symptoms of abuse was low in the 
second set of surveys (0.3% alcohol, 0.2% drugs). Regression-based imputation models were built in 
random half-samples of the new surveys and validated in the other half. There were minimal differences 
for imputed and actual reported cases in the validation dataset for age, gender and quantity; more mental 
disorders and days out of role were found in the imputed cases. Concordance between imputed and 
observed dependence cases in the full sample was high for alcohol [sensitivity 88.0%, specificity 99.8%, 
total classification accuracy (TCA) 99.5%, area under the curve (AUC) 0.94] and drug dependence 
(sensitivity 100.0%, specificity 99.8%, TCA 99.8%, AUC 1.00). This provides cross-national evidence of the 
small degree to which lifetime dependence occurs without symptoms of abuse. Imputation of substance 
dependence in the earlier WMH surveys improved estimates of dependence. 
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 The WHO World Mental Health (WMH) Survey Initiative uses the Composite 
International Diagnostic Interview (CIDI) for data collection and operationalizes diagnoses 
using DSM-IV criteria. The first 13 WMH surveys used CIDI version 3.0, which only 
assessed substance dependence among respondents with a history of substance abuse, while 
subsequent surveys also assessed substance dependence without symptoms of abuse. The aim 
of the current report is to compare results across the two sets of surveys to assess the 
implications of the revised skip logic and develop an imputation model for missing values of 
lifetime dependence without symptoms of abuse in the earlier surveys. Prevalence of lifetime 
dependence without symptoms of abuse was low in the second set of WMH surveys (0.3% 
for alcohol and 0.2% for drugs). Regression-based imputation models were built in random 
half-samples of the new surveys and validated in the other half-samples. There were minimal 
difference in the distributions of imputed and reported cases in the validation dataset for 
important correlates such as age, gender and quantity though higher numbers of additional 
mental disorders and number of days out of role were found in the imputed than reported 
cases. Concordance between imputed and observed estimates of total lifetime dependence in 
the full sample was high both for alcohol dependence (sensitivity 88.0%, specificity 99.8%, 
TCA 99.5% and AUC 0.94) and drug dependence (sensitivity 100.0%, specificity 99.8%, 
TCA 99.8% and AUC 1.00). This study provides cross-national evidence of the degree to 
which each of lifetime alcohol dependence and lifetime drug dependence occur without 
symptoms of abuse. Additionally imputation of substance dependence without symptoms of 
abuse in the earlier WMH surveys will result in improved estimates of lifetime prevalence for 
comparison with other epidemiological studies both cross-nationally and over time. 
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Alcohol and drug use are estimated to be responsible for around 5% of global disease 
burden and are among the biggest risk factors for burden of disease (Lim et al. 2012). 
However major challenges exist in accurately estimating the population prevalence of 
substance use and substance use disorders, particularly for illicit drugs (Degenhardt and Hall 
2012). Where estimates do exist, they can vary substantially depending on the 
conceptualisation and classification of use disorder (Lago et al. 2016), limitations from 
balancing the needs of comparability and cultural specificity (Beals et al. 2003), interviewer 
mode (Turner et al. 2005) and the survey instrument (Grant et al. 2007). Epidemiological 
surveys such as the World Health Organization (WHO) World Mental Health (WMH) 
surveys provide valid, in-depth, data on the prevalence and correlates of mental disorders in 
the general population (Kessler and Üstün 2004), with the data collected in a consistent way 
across countries to allow cross-national comparison (Harkness et al. 2008). The WMH 
surveys individually are also a rich source of information for within country research (Kessler 
et al. 2003, Alonso et al. 2004, Kawakami et al. 2005, Slade et al. 2009). 
Substance-related disorders are defined in DSM-IV as “disorders related to the taking 
of a drug of abuse (including alcohol), to the side effects of a medication, and to toxin 
exposure” (American Psychiatric Association 1994). The DSM-IV divides substance-related 
disorders into two groups, substance use disorders (substance dependence and substance 
abuse) and substance-induced disorders. Substance dependence requires a cluster of 
cognitive, behavioural and physiological symptoms resulting in continued use despite 
significant problems that can involve tolerance, withdrawal and compulsive behaviour. 
Substance abuse is defined as a maladaptive pattern of use, with recurrent and significant 
adverse consequences. Although symptoms of abuse commonly occur prior to those of 
dependence (Kessler and Merikangas 2007), abuse is often neither mild nor prodromal to 
dependence (Hasin et al. 2013). Furthermore, a prominent U.S. survey found that a 
substantial proportion of persons with dependence never had prior symptoms of abuse (Hasin 
and Grant 2004) and that this was especially true for women and minorities, leading to the 
conclusion that failure to assess dependence among people without symptoms of abuse would 
not only lead to under-detection of dependence but would do so selectively in vulnerable 
segments of the population. Based on these observations, a consensus view emerged that 
symptoms of dependence should be assessed among substance users whether or not they have 
symptoms of abuse (Cottler 2007, Grant et al. 2007).  
Prior to the time this consensus emerged, the WHO WMH Survey Initiative (Kessler 
and Üstün 2008) carried out a number of large national epidemiological surveys using a 
version of the WMH–Composite International Diagnostic Interview (CIDI) (Kessler and 
Üstün 2004) that only assessed symptoms of substance dependence among respondents with 
a history of symptoms of abuse. The WMH investigators subsequently revised the CIDI to 
also include assessments of dependence among respondents without symptoms of abuse in 
future WMH surveys. In an effort to evaluate the implications of this change and to develop 
an imputation model for missing values in the first 13 WMH surveys, an analysis of the 
prevalence and predictors of DSM-IV lifetime dependence without symptoms of abuse 
among non-abusing lifetime users was carried out in the nine more recent WMH surveys. The 
results of that analysis are presented in the current report. Imputation of dependence without 
symptoms of abuse in the earlier WMH surveys will improve the cross-national 
comparability of estimates of substance dependence (Degenhardt et al. 2008) and related 
measures such as global burden of disease (Degenhardt et al. 2013), improve comparisons 
with other epidemiological studies (Grant et al. 2004) and provide improved evidence when 
assessing changes in the prevalence of substance use disorders over time(Blanco et al. 2007, 






The study was carried out using data from nine recent WMH surveys with the revised 
skip logic. One of these surveys was carried out in a country classified by the World Bank 
(The World Bank 2015) as lower-middle income (a national survey in Iraq), three in 
countries classified upper-middle income (a national survey in Romania and regional surveys 
in Sao Paulo Brazil and Medellin Colombia), and five in countries classified high income 
(national surveys in Australia, Northern Ireland, Portugal, and Poland and a regional survey 
in Murcia Spain). As Portugal did not assess drug dependence, their data was used only to 
study alcohol dependence. Most surveys were based on a multi-stage clustered area 
probability sampling design of adult (ages 18 and over) household residents. One randomly-
selected resident was interviewed in each sampled household. The average response rate 
across surveys was 64.7% and the total sample size was 44,341. A detailed description of 
WMH sampling procedures is presented elsewhere (Heeringa et al. 2008).     
Insert Table 1 here 
Field procedures  
Interviews were carried out face-to-face in the homes of respondents after obtaining 
informed consent using procedures approved by local Institutional Review Boards. The 
interview schedule was developed in English and translated into other languages using a 
standardized WHO translation, back-translation, and harmonisation protocol (Harkness et al. 
2008). Bilingual supervisors from each country were trained and supervised by the WMH 
Data Collection Coordination Centre to guarantee cross-national consistency in training and 
field procedures (Harkness et al. 2008). The interviews were administered by trained lay 
interviewers.  
Interviews were carried out in two parts in all surveys other than Australia, Romania 
and Iraq, where the full interview was administered to all respondents. Part I, which was 
completed by all respondents, assessed core mental disorders. Part II, which was 
administered to 100% of Part I respondents with any lifetime disorder and a probability 
subsample of other respondents, assessed correlates and disorders of secondary interest. Data 
from Part II were weighted to account for the under-representation of Part I non-cases, and to 
make the weighted Part II sample equivalent to the Part I sample in prevalence and correlates 
of disorders. The Part II data, which are used here, were also weighted to adjust for 
differences in within-household probabilities of selection and discrepancies between the 
sample and population on a cross-classification of Census socio-demographic and geographic 
variables. A more detailed description of the WMH weighting procedures is available 
elsewhere (Heeringa et al. 2008).  
Diagnostic Instrument 
In the nine surveys used in this study, DSM-IV disorders were assessed using the 
WHO CIDI Version 3.0. The substance use disorders assessed were alcohol abuse, alcohol 
dependence, drug abuse and drug dependence. The anxiety disorders assessed were panic 
disorder (with or without agoraphobia), agoraphobia without a history of panic disorder, 
generalized anxiety disorder, posttraumatic stress disorder, separation anxiety disorder, social 
phobia, specific phobia, and obsessive compulsive disorder. The mood disorders assessed 
were major depressive disorder, dysthymic disorder, and bipolar disorder. As detailed 
elsewhere (Haro et al. 2006), generally good concordance was found between diagnoses 
based on the CIDI and diagnoses based on blinded clinical reappraisal interviews with the 
Structured Clinical Interview for DSM-IV, research version (SCID) (First et al. 2002). A 
series of 5 questions was used to operationalize the symptom criteria for alcohol abuse and a 




questions were asked of people who, in the year they drank most, consumed alcohol at or 
above a quantity/frequency threshold of one or more drinks per week or, if drinking less 
often, three or more drinks per day on the days they drank. This threshold was set slightly 
higher in the Australian survey (drinking at least one drink three or more days per week or, if 
drinking less often, three or more drinks per day on the days they drank). A further 15 
questions were used to assess criteria for Drug Use Disorders (DUD), 4 questions assessing 
drug abuse and 11 questions operationalizing drug dependence. These questions were asked 
of respondents who had ever used medicines for non-medical reasons or had ever used illicit 
drugs (henceforth referred to ‘used drugs’). A diagnosis of substance abuse or substance 
dependence requires the cluster of symptoms to occur within the same 12 month period, and 
the resulting diagnoses are defined for both past 12 months and lifetime. There were some 
slight variations in the assessment of DUDs across surveys because respondents were asked 
about their use of a list of drugs that varied slightly across surveys, although most had an ‘any 
other drug’ category. The Australian and Polish surveys included additional detail, assessing 
DUD separately for each drug/drug type; however this information was generalizable to any 
DUD.  
Statistical Analysis 
Statistical modelling was carried out in SAS v9.3 and SUDAAN v11.0 using logistic 
regression to predict lifetime alcohol dependence among respondents who met the drinking 
threshold described above but had no symptoms of abuse, and lifetime drug dependence 
among respondents who had used drugs without symptoms of abuse. Part II respondents in 
each of the nine WMH surveys that assessed dependence without symptoms of abuse were 
divided into two random halves then pooled: the first half a pooled ‘training dataset’ for 
building the imputation model and the second half a pooled ‘validation dataset’ for 
independent assessment of predictive accuracy. 
A broad set of potential predictors was considered for alcohol dependence without 
symptoms of abuse, including age, sex, other mental and drug use disorders, age of first use, 
age of first regular use (drinking at least 12 standard drinks per year), frequency of drinking 
at least one standard drink in the one year in life when drinking most, lifetime and current 
smoking status, history of drug use, and high income country. Several variables were 
investigated as predictors of lifetime drug dependence without abuse: number of drug used, 
drug types, number of mental health diagnoses, alcohol abuse and dependence, age, sex, age 
of onset of first drug use, days out of role, education and high income country.  We focused 
largely on survey items available in all surveys, the exception being drug use variables that 
were available in all surveys other than Portugal. A full list of variables is included in 
Appendix 1, Table A1 (for alcohol) and Appendix 2 Table A3 (for drugs).  
Exploratory analysis of the training dataset showed that drinkers who either drank 
rarely or who drank relatively small quantities on the days they drank were highly unlikely to 
have alcohol dependence, leading us to exclude these respondents from further analysis and 
code them as not having dependence without symptoms of abuse in the imputation. These 
‘light drinkers’ represented 71.3% of all lifetime drinkers and 12.0% of respondents with 
lifetime alcohol dependence.  
Once these light drinkers were removed from the training  dataset, four alternate 
models were estimated. Model A included substance use variables (see Appendix 1Table A1) 
and sex as predictors. Predictors related to age-of-onset and consumption were treated as 
continuous. Model B added to Model A an adjustment to the intercept for surveys from high 
income countries. Model C then dichotomized the age and consumption variables. Model D, 
finally, used forward stepwise regression with a .05-level entry criterion to select the subset 




Individual-level imputes of lifetime dependence without abuse based on each of the 
above models were made in the validation sample and compared to reported diagnoses. This 
was done as follows. The model coefficients developed using the training dataset were 
applied to data in the validation dataset to generate predicted probabilities of dependence 
without symptoms of abuse. For alcohol, this was done among those who met the minimum 
alcohol consumption threshold described previously, while for drugs it was done in the 
subsample of respondents who reported lifetime drug use. We used a pseudo-benchmark by 
assuming the ratio of prevalence of dependence without symptoms of abuse to dependence 
with abuse for alcohol, and similarly for drugs, would be the same across countries. We 
calculated this ratio across the nine surveys without the skip error and used it to generate an 
expected number of cases of dependence without symptoms of abuse in these same surveys.  
Within each country, respondents were imputed to a diagnosis of dependence without 
symptoms of abuse when the predicted probability was above the threshold required to 
achieve this ratio.  
Multiple Imputation (MI) (Rubin 1987) is an approach to imputation which can 
improve statistical inference by incorporating uncertainty into the imputed data through the 
creation of several imputed values. No missing data technique is optimal for every missing 
data situation, and MI is not the only principled method and isn’t necessarily the best for any 
given problem (Schafer 1999). The improvement in variance estimation of parameters due to 
missing data is dependent on the amount of missing data (Rubin 1987). The nine surveys 
used in this study provide an estimate of the size of the missing data, that is an estimated 
0.3% population prevalence of lifetime alcohol dependence without abuse and a 
corresponding figure of 0.2% for drugs. As the number of imputed values was very small, we 
used a single imputation method rather than multiple imputation. This also reduces the 
complexity of analysis for future use of the datasets. 
We assessed the relative performance of the predictive models in the validation 
dataset using McNemar’s chi-square test, and the Akaike and Bayesian Information Criterion 
(AIC and BIC respectively). The best performing model was further assessed by comparing 
imputed and reported cases of dependence without symptoms of abuse in the validation 
dataset on a set of covariates including age, gender, consumption, and comorbidities. 
Lastly, the diagnostic accuracy resulting from imputed data was reported on the 
complete pooled dataset of nine surveys (eight surveys  for drug dependence). The 
classification of lifetime substance dependence, that is reported cases of dependence with 
symptoms of abuse in combination with imputed cases of dependence without symptoms of 
abuse, was assessed for re-production of reported population prevalence, sensitivity, 
specificity, positive predictive value (PPV), negative predictive value (NPV), Total 
Classification Accuracy (TCA) and Area Under the Curve (AUC). These calculations are not 
able to be performed on the 13 imputed surveys where dependence without symptoms of 
abuse was not assessed.  
 
Results 
Prevalence of lifetime alcohol and drug dependence  
Estimates of lifetime prevalence of alcohol dependence with a history of abuse ranged 
from 0.1 to 4.2% and averaged 2.2% in the nine surveys with the updated skip logic. 
Prevalence of lifetime alcohol dependence with or without a history of abuse was in the range 
0.2-4.8% and averaged 2.5% (Table 2). The proportion of respondents without a lifetime 
history of abuse among those meeting lifetime criteria for alcohol dependence was in the 
range 4.4-73.9% and averaged 13.5% over all surveys. Pairwise comparisons showed this 




dependence cases in total), and all other surveys (p-values ranged from 0.0% to 1.2%). No 
statistically significant differences were found in pairwise comparisons amongst the other 
surveys (p-values ranged from 5.7% to 98.2%). Even though the number of people who used 
drugs was much smaller than the number who used alcohol, the proportion of respondents 
with lifetime drug dependence who had never met criteria for abuse (0.2% dependence 
without symptoms of abuse out of 1.3% dependence with or without symptoms of abuse) was 
similar to the proportion of respondents with alcohol dependence who never had symptoms 
of alcohol abuse.  
Insert Table 2 here 
Validation of the imputation models 
The final model for predicting alcohol dependence without symptoms of abuse 
included the following covariates: sex, four or more mental health diagnoses, at least one day 
out of role, and survey in high income country (AIC=229.4, BIC = 251.4) (see Table 3). The 
model for predicting drug dependence without symptoms of abuse consisted of the following 
covariates: sex, four or more mental health diagnoses, alcohol dependence with or without 
abuse, used four or more different drugs, and high income country (AIC=205.2, BIC=239.3) 
compared to the model containing all predictors (AIC=210.0, BIC=289.4).  
Insert Table 3 here 
The imputation method was also evaluated for bias in the validation dataset by 
comparing various attributes of reported cases of alcohol dependence without symptoms of 
abuse with imputed cases. As there was an overlap between the groups (true positives) 
violating independence assumptions for standard significance testing methods, we present the 
mean and 95% CI for each characteristic to determine if there are any non-overlapping CIs 
that might raise concerns. The distributions were generally consistent, with overlap in the CIs 
for age, gender, average drinks per day and proportion who used drugs, although the imputed 
cases had higher rates of mental disorders (2.9 in imputed cases compared to 1.5 for reported 
cases) and mean days out of role (5.4 for imputed cases compared to 1.6 for reported cases).  
Insert Table 4 here 
The finals models were then used to predict dependence without symptoms of abuse in the 
pooled data from surveys with the revised skip logic (pooled sample details shown in Table 
2). The resulting lifetime alcohol dependence Total Classification Accuracy (TCA) was very 
high (99.5%), as were sensitivity (88.0%), specificity (99.8%), and AUC (0.94).  Lifetime 
drug dependence was also found to have excellent concordance with reported diagnoses 
(TCA = 98.1%, sensitivity = 27.5%, specificity = 98.9%, AUC = 0.63) (individual models 
not shown)  
Insert Table 5 here 
Discussion 
Contrary to the conclusions in the U.S. survey which found that 33.7% of respondents did not 
additionally meet criteria for abuse (Hasin and Grant 2004), and led to the changes in the 
CIDI skip rules, the nine recent WMH surveys that assessed alcohol and drug dependence 
without symptoms of abuse found that such cases were quite rare in comparison to the 
prevalence of dependence with a history of abuse. Analysis of the data patterns in these nine 
countries demonstrated that an imputation model could be developed for the small proportion 
of respondents who met criteria for lifetime alcohol dependence without symptoms of abuse 
(0.3%) compared to all respondents with lifetime alcohol dependence (2.5%), and similarly 
for those who met criteria for lifetime drug dependence without symptoms of abuse (0.2%) 
compared to all respondents with lifetime drug dependence (1.3%). The imputation models 
resulted in consistent estimates of prevalence of lifetime dependence in the full samples of 




imputed data)  and drug dependence in the eight surveys where this was assessed (1.3% 
pooled survey estimate, 1.5% using imputed data), with strong individual-level classification 
accuracy metrics and similar distributions of important correlates such as age, gender and 
quantity, though higher numbers of additional mental disorders and number of days out of 
role were found in the imputed than reported cases. The U.S. study (Hasin and Grant 2004) 
also presented percentages of alcohol dependence with and without symptoms of abuse by 
sex, race and age and concluded that the proportion of cases without symptoms of abuse 
varied by gender and race. In contrast this study developed a predictive model, finding gender 
and other variables to be predictive of alcohol dependence without symptoms of abuse. These 
results strongly suggest that these imputation models can be used to adjust for the absence of 
information about substance dependence without symptoms of abuse in early WMH surveys. 
In some surveys this will result in slightly higher estimates of the prevalence of lifetime drug 
or alcohol dependence 
 
Limitations 
As with most real-world missing data problems, we were unable to assess the accuracy of the 
imputed values in the original 13 WMH surveys even though we were able to do so in the 
validation dataset  of the more recent surveys. However, an advantage of having the WMH 
Survey Initiative is that a consistent method of data collection has been employed across a 
large number of countries representing varied income levels. This gives us confidence that we 
are using a broad set of data to develop and assess an imputation method that is applied to a 
small number of cases of missing data across a large number of countries. As imputed values 
are appropriately flagged in the dataset, sensitivity analysis may be carried out in future 
substantive analyses to determine the impact of imputation on any statistical modelling. 
However, based on the small number of missing values, we anticipate that in most cases this 
impact will be small. The small number of cases of dependence and dependence without 
abuse lead to confidence intervals of width 20-30% when estimating the proportion of 
respondents with dependence who do not have symptoms of abuse by survey (excluding 
Iraq), however the pooled survey estimate across the nine surveys has an interval with width 
less than 10% for both alcohol and drugs.  
Some of the earlier WMH surveys were carried out 15 years ago. Data from older surveys 
may not be as precise for estimating current prevalence as later surveys, but this does not 
diminish the value of the rich data source for understanding phenomenon related to substance 
use. This includes differential patterns of use across countries, and understanding and 
predicting transitions between use and use disorders/remission among those who use alcohol 
and/or drugs. 
The list of drugs asked about varied slightly across surveys but in most cases a catch all 
category was included. We did not impute drug dependence for specific drugs, only lifetime 
dependence among those who use drugs, so anticipate no major impact. 
Conclusion 
These results strongly suggest that these imputation models can be used to adjust for the 
absence of information about lifetime DSM-IV alcohol and drug dependence without 
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Table 1: WMH sample characteristics by World Bank income categoriesa 
Country by income category 
Surveyb Sample characteristicsc Field dates Age range Sample Size Response rated 
     Part I Part II  
I. Low and lower middle income countries 
     
Iraq 
IMHS Nationally representative. 2006-7 18-96 4,332 4,332 95.2 
TOTAL 
    (4,332) (4,332) 95.2 
II. Upper-middle income countries      
Brazil - São Paulo 
São Paulo Megacity São Paulo metropolitan area. 2005-8 18-93 5,037 2,942 81.3 
Colombia – Medellinf 
MMHHS Medellin metropolitan area 2011-12 19-65 3,261 1,673 97.2 
Romania 
RMHS Nationally representative. 2005-6 18-96 2,357 2,357 70.9 
TOTAL 
    (10,655) (6,972) 82.8 
III. High-income countries      
Australiae 
NSMHWB Nationally representative. 2007 18-85 8,463 8,463 60.0 
Northern Ireland 
NISHS Nationally representative. 2005-8 18-97 4,340 1,986 68.4 
Poland 
EZOP Nationally representative 2010-11 18-65 10,081 4,000 50.4 
Portugal 
NMHS Nationally representative. 2008-9 18-81 3,849 2,060 57.3 
Spain - Murcia 
PEGASUS- Murcia Murcia region  2010-12 18-96 2,621 1,459 67.4 
TOTAL 
    (29,354) (17,968) 57.5 
IV. TOTAL 
    (44,341) (29,272) 64.7 
a The World Bank (2012) Data. Accessed May 12, 2012 at: http://data.worldbank.org/country. Some of the WMH countries have moved into new income categories since the surveys were conducted. The 
income groupings above reflect the status of each country at the time of data collection. The current income category of each country is available at the preceding URL. 
b IMHS (Iraq Mental Health Survey); MMHHS (Medellín Mental Health Household Study); RMHS (Romania Mental Health Survey); NSMHWB (National Survey of Mental Health and Wellbeing); 
NISHS (Northern Ireland Study of Health and Stress); EZOP (Epidemiology of Mental Disorders and Access to Care Survey); NMHS (Portugal National Mental Health Survey); PEGASUS-Murcia 
(Psychiatric Enquiry to General Population in Southeast Spain-Murcia).  
c Most WMH surveys are based on stratified multistage clustered area probability household samples in which samples of areas equivalent to counties or municipalities in the U.S. were selected in the first 
stage followed by one or more subsequent stages of geographic sampling (e.g., towns within counties, blocks within towns, households within blocks) to arrive at a sample of households, in each of which 
a listing of household members was created and one or two people were selected from this listing to be interviewed. No substitution was allowed when the originally sampled household resident could not 
be interviewed. These household samples were selected from Census area data in all countries. 6 of the 9 surveys are based on nationally representative household samples. The Polish sample was not a 
household sample but a nationally representative sample of individuals sampled from the population register.  
d The response rate is calculated as the ratio of the number of households/individuals in which an interview was completed to the number of households/individuals originally sampled, excluding from the 
denominator households known not to be eligible either because of being vacant at the time of initial contact or because the residents were unable to speak the designated languages of the survey. The 
weighted average response rate is 64.7%.  
e For the purposes of cross-national comparisons we limit the sample to those 18+. The NSMHWB surveyed respondents aged 16-85 with a total sample size of 8841. The response rate reported here refers 
to the full survey sample response rate. 
f Colombia moved from the "lower and lower-middle income" to the "upper-middle income" category between 2003 (when the Colombian National Study of Mental Health was conducted) and 2010 (when the 




Table 2: Lifetime dependence (with or without symptoms of abuse) and lifetime dependence 
without symptoms of abuse in surveys with the revised skip logic  















without symptoms of 
abuse 
















% (95% CI) 
Iraq 4,332 0.2 (0.1) 0.2 (0.1) 73.9  (36.8,100.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0,0.0) 
Brazil - 
São Paulo 




1,673 4.8 (0.8) 0.6 (0.3) 12.6 ( 0.0,  25.7) 1.9 (0.4) 0.0 (0.0) 2.4  ( 0.0,  5.2) 
Romania 2,357 0.7 (0.2) 0.1 (0.1) 8.8 ( 0.0,  25.1) 0.0 (0.0) 0.0 (0.0) 0.0  ( 0.0,  0.0) 
Australia 8,463 4.0 (0.3) 0.6 (0.1) 14.9 ( 9.1,  20.8) 2.9 (0.3) 0.0 (0.0) 10.7  ( 5.7, 15.6) 
Spain - 
Murcia 
1,459 1.5 (0.5) 0.1 (0.1) 4.4 ( 0.0,  13.0) 1.3 (0.5) 0.0 (0.0) 0.0  ( 0.0,   0.0) 
Northern 
Ireland 
1,986 2.5 (0.4) 0.2 (0.1) 7.5 ( 0.0,  15.3) 0.6 (0.2) 0.1 (0.1) 10.8  ( 0.0, 25.2) 
Poland 4,000 2.2 (0.3) 0.2 (0.1) 7.6 ( 1.3,  14.0) 0.2 (0.1) 0.1 (0.1) 54.3  (22.3, 86.3) 
Portugal 2,060 1.3 (0.3) 0.3 (0.2) 21.2 ( 3.6,  38.8) - - - - 
TOTAL 31,367 2.5 (0.1) 0.3 (0.0) 13.5 ( 9.9, 17.1) 1.3 (0.1) 0.2 (0.0) 12.1 ( 8.0,  16.2) 
a.  Part I sample weights used in Australia, Romania and Iraq (which did not include a Part II), and in Brazil - São Paulo  





Table 3: Model fit in validation dataset for imputation of alcohol dependence without 
symptoms of abuse (N=1,805) 
Model McNemar χ2 AICe BICf 
model Aa 0.7 (p=0.42) 254.7 293.1 
model Bb2 0.6 (p=0.43) 239.1 310.5 
model Cc3  0.7 (p=0.40) 246.5 311.8 
model Dd4 0.7 (p=0.40) 231.4 258.9 
a. Model A included substance use variables (Appendix 1 Table A1) and sex as predictors. Predictors related to age and 
consumption were treated as continuous. 
b. Model B included substance use variables as in Model A but also included an adjustment to the intercept for surveys 
from high income countries.  
c. Model C included the same predictors as Model A, however the age and consumption variables were dichotomised. 
d. Model D was a stepwise regression using the full set of covariates in Model C. 
e. Akaike Information criterion 





Table 4: Comparison of imputed vs known cases of alcohol dependence without symptoms of 




mean/proportion (95% CI)  
(N=90)   
Imputed DWOA Distribution 
 weighteda mean/proportion 
 (N=89)  
Mean age (95% CI)  40.8  (38.0, 43.7) 42.9  (40.0, 45.7) 
Proportion Males (95% CI) 0.6  (0.5, 0.8) 0.6  (0.5, 0.7) 
Mean drinks per day (95% CI) 10.3  (4.4, 16.2) 12.6  (8.5, 16.7) 
Mean additional mental disorders  (95% CI) 1.5  (1.1, 1.8) 2.9  (2.5, 3.3) 
Mean days out of roleb (95% CI) 1.6  (1.0, 2.1) 5.4  (4.7, 6.2) 
Proportion used drugs (95% CI) 0.4  (0.3, 0.5) 0.3  (0.2, 0.5) 
a. Part I sample weights used in Australia, Romania and Iraq (which did not include a Part II), and in São Paulo - 
Brazil where alcohol use disorders were assessed in Part I. Part II weights used for all other surveys.  
b. Respondents were asked “Beginning yesterday and going back 30 days, how many days out of the past 30 were 
you totally unable to work or carry out your normal activities because of problems with either your physical health, 





Table 5: Final model performance for imputation of alcohol dependence without symptoms 
of abuse in pooled samplea of surveys with revised skip logic  
Criteria 
Alcohol dependence 





Prevalence dependence (%, weighted, reported data) 2.5 (0.1) 1.3 (0.2)  
Prevalence dependence (%, weighted, imputed data) 2.4 (0.1) 1.5 (0.2) 
Sensitivity (s.e.) 88.0 (1.2) 100.0 (0.0) 
Specificity (s.e.) 99.8 (0.0) 99.8 (0.0) 
Positive Predicted Value  (s.e.) 92.3 (0.7) 89.3 (1.0) 
Negative Predicted Value  (s.e.) 99.7 (0.0) 100.0 (0.0) 
Total Classification Accuracy  (s.e.) 99.5 (0.1) 99.8 (0.1) 
AUC   0.94 1.00 
a. Surveys included in pooled sample were Iraq, Colombia - Medellin, Spain - Murcia, Portugal (alcohol only), Poland,  
Australia, Northern Ireland and Romania  
b. Sample weighted estimates for prevalence and all operator characteristics 
 
